NL6808107A - - Google Patents

Info

Publication number
NL6808107A
NL6808107A NL6808107A NL6808107A NL6808107A NL 6808107 A NL6808107 A NL 6808107A NL 6808107 A NL6808107 A NL 6808107A NL 6808107 A NL6808107 A NL 6808107A NL 6808107 A NL6808107 A NL 6808107A
Authority
NL
Netherlands
Application number
NL6808107A
Other versions
NL161768B (nl
NL161768C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6808107A publication Critical patent/NL6808107A/xx
Publication of NL161768B publication Critical patent/NL161768B/xx
Application granted granted Critical
Publication of NL161768C publication Critical patent/NL161768C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6808107.A 1967-06-09 1968-06-08 Werkwijze ter bereiding van een gestageen werkzaam 4,6-dichloor-4,6-pregnadieen, werkwijze ter bereiding van een geneesmiddel met gestagene werking, alsmede gevormd geneesmiddel. NL161768C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967SC040852 DE1643027B2 (de) 1967-06-09 1967-06-09 4,6-dichlor-delta hoch 4,6- steroide der pregnanreihe

Publications (3)

Publication Number Publication Date
NL6808107A true NL6808107A (cg-RX-API-DMAC10.html) 1968-12-10
NL161768B NL161768B (nl) 1979-10-15
NL161768C NL161768C (nl) 1980-03-17

Family

ID=7435899

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6808107.A NL161768C (nl) 1967-06-09 1968-06-08 Werkwijze ter bereiding van een gestageen werkzaam 4,6-dichloor-4,6-pregnadieen, werkwijze ter bereiding van een geneesmiddel met gestagene werking, alsmede gevormd geneesmiddel.

Country Status (17)

Country Link
US (1) US3789087A (cg-RX-API-DMAC10.html)
AT (1) AT280499B (cg-RX-API-DMAC10.html)
BE (1) BE716258A (cg-RX-API-DMAC10.html)
BR (1) BR6899582D0 (cg-RX-API-DMAC10.html)
CH (1) CH560230A5 (cg-RX-API-DMAC10.html)
CS (1) CS163723B2 (cg-RX-API-DMAC10.html)
DE (1) DE1643027B2 (cg-RX-API-DMAC10.html)
DK (2) DK124610B (cg-RX-API-DMAC10.html)
ES (1) ES354795A1 (cg-RX-API-DMAC10.html)
FI (1) FI45176C (cg-RX-API-DMAC10.html)
FR (2) FR1588812A (cg-RX-API-DMAC10.html)
GB (1) GB1240339A (cg-RX-API-DMAC10.html)
NL (1) NL161768C (cg-RX-API-DMAC10.html)
NO (1) NO129522B (cg-RX-API-DMAC10.html)
PL (1) PL73566B1 (cg-RX-API-DMAC10.html)
SE (1) SE341396B (cg-RX-API-DMAC10.html)
YU (1) YU33977B (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015794A1 (en) 1994-11-22 1996-05-30 Balance Pharmaceuticals, Inc. Compositions and methods for contraception and for treatment of benign gynecological disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838773A (en) * 1955-07-20 1960-06-22 Farmaceutici Italia 4-substituted steroid compounds and preparation thereof
US3452058A (en) * 1958-11-13 1969-06-24 Syntex Corp 6-substituted-6-dehydro androstanes and pregnanes
GB1050218A (cg-RX-API-DMAC10.html) * 1964-10-13
DE1593516C3 (de) * 1966-08-25 1975-05-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen 4-Halogen-1,2 alpha; 6,7 betabismethylen-delta hoch 4-3-ketosteroide, Verfahren zu ihrer Herstellung sowie diese Steroide enthaltende Mittel
US3707537A (en) * 1969-01-08 1972-12-26 Hoffmann La Roche 4-chloro-4,6-diene-6-halo or lower alkyl steroids

Also Published As

Publication number Publication date
ES354795A1 (es) 1969-11-01
CS163723B2 (cg-RX-API-DMAC10.html) 1975-11-07
GB1240339A (en) 1971-07-21
FI45176C (fi) 1972-04-10
YU33977B (en) 1978-09-08
DK128189B (da) 1974-03-18
DE1643027B2 (de) 1977-12-08
DE1643027A1 (de) 1971-04-15
DK124610B (da) 1972-11-06
BE716258A (cg-RX-API-DMAC10.html) 1968-12-09
SE341396B (cg-RX-API-DMAC10.html) 1971-12-27
PL73566B1 (cg-RX-API-DMAC10.html) 1974-10-31
AT280499B (de) 1970-04-10
FI45176B (cg-RX-API-DMAC10.html) 1971-12-31
YU127868A (en) 1978-02-28
NL161768B (nl) 1979-10-15
FR1588812A (cg-RX-API-DMAC10.html) 1970-03-16
NO129522B (cg-RX-API-DMAC10.html) 1974-04-22
DE1643027C3 (cg-RX-API-DMAC10.html) 1978-08-17
NL161768C (nl) 1980-03-17
US3789087A (en) 1974-01-29
BR6899582D0 (pt) 1973-05-10
CH560230A5 (cg-RX-API-DMAC10.html) 1975-03-27
FR8342M (cg-RX-API-DMAC10.html) 1970-12-21

Similar Documents

Publication Publication Date Title
FR8342M (cg-RX-API-DMAC10.html)
AU2277767A (cg-RX-API-DMAC10.html)
BE704230A (cg-RX-API-DMAC10.html)
BE702254A (cg-RX-API-DMAC10.html)
BE709499A (cg-RX-API-DMAC10.html)
BE706940A (cg-RX-API-DMAC10.html)
BE713932A (cg-RX-API-DMAC10.html)
BE708774A (cg-RX-API-DMAC10.html)
BE705250A (cg-RX-API-DMAC10.html)
BE710450A (cg-RX-API-DMAC10.html)
BE692654A (cg-RX-API-DMAC10.html)
BE162295A (cg-RX-API-DMAC10.html)
BE708900A (cg-RX-API-DMAC10.html)
BE705387A (cg-RX-API-DMAC10.html)
BE708118A (cg-RX-API-DMAC10.html)
BE708763A (cg-RX-API-DMAC10.html)
BE708622A (cg-RX-API-DMAC10.html)
BE707632A (cg-RX-API-DMAC10.html)
BE707129A (cg-RX-API-DMAC10.html)
BE692922A (cg-RX-API-DMAC10.html)
BE708321A (cg-RX-API-DMAC10.html)
BE708937A (cg-RX-API-DMAC10.html)
BE708724A (cg-RX-API-DMAC10.html)
BE711062A (cg-RX-API-DMAC10.html)
BE706043A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: SCHERING